5-membered heteroaryl carboxamide compounds for treatment of hbv

TW202641806APending Publication Date: 2026-10-16ASSEMBLY BIOSCIENCES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114149718
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-04-22
Filing Date
2021-04-22
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080719_001
    Figure TWG2TA001080719_001
  • Figure TWG2TA001080719_002
    Figure TWG2TA001080719_002
  • Figure TWG2TA001080719_003
    Figure TWG2TA001080719_003
Patent Text Reader

Abstract

The present disclosure provides, in part, 5-membered heteroaryl carboxamide compounds, and pharmaceutical compositions thereof, useful for disruption of HBV core protein assembly, and methods of treating Hepatitis B (HBV) infection.
Need to check novelty before this filing date? Find Prior Art